These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Inhibition of myostatin does not ameliorate disease features of severe spinal muscular atrophy mice. Sumner CJ, Wee CD, Warsing LC, Choe DW, Ng AS, Lutz C, Wagner KR. Hum Mol Genet; 2009 Sep 01; 18(17):3145-52. PubMed ID: 19477958 [Abstract] [Full Text] [Related]
25. Ciliary neurotrophic factor-induced sprouting preserves motor function in a mouse model of mild spinal muscular atrophy. Simon CM, Jablonka S, Ruiz R, Tabares L, Sendtner M. Hum Mol Genet; 2010 Mar 15; 19(6):973-86. PubMed ID: 20022887 [Abstract] [Full Text] [Related]
26. Synthesis and biological evaluation of novel 2,4-diaminoquinazoline derivatives as SMN2 promoter activators for the potential treatment of spinal muscular atrophy. Thurmond J, Butchbach ME, Palomo M, Pease B, Rao M, Bedell L, Keyvan M, Pai G, Mishra R, Haraldsson M, Andresson T, Bragason G, Thosteinsdottir M, Bjornsson JM, Coovert DD, Burghes AH, Gurney ME, Singh J. J Med Chem; 2008 Feb 14; 51(3):449-69. PubMed ID: 18205293 [Abstract] [Full Text] [Related]
27. Chronic treatment with lithium does not improve neuromuscular phenotype in a mouse model of severe spinal muscular atrophy. Dachs E, Piedrafita L, Hereu M, Esquerda JE, Calderó J. Neuroscience; 2013 Oct 10; 250():417-33. PubMed ID: 23876328 [Abstract] [Full Text] [Related]
30. Establishing a standardized therapeutic testing protocol for spinal muscular atrophy. Tsai LK, Tsai MS, Lin TB, Hwu WL, Li H. Neurobiol Dis; 2006 Nov 10; 24(2):286-95. PubMed ID: 16952456 [Abstract] [Full Text] [Related]
31. Calpain Inhibition Increases SMN Protein in Spinal Cord Motoneurons and Ameliorates the Spinal Muscular Atrophy Phenotype in Mice. de la Fuente S, Sansa A, Periyakaruppiah A, Garcera A, Soler RM. Mol Neurobiol; 2019 Jun 10; 56(6):4414-4427. PubMed ID: 30327977 [Abstract] [Full Text] [Related]
32. The zinc finger protein ZPR1 is a potential modifier of spinal muscular atrophy. Ahmad S, Wang Y, Shaik GM, Burghes AH, Gangwani L. Hum Mol Genet; 2012 Jun 15; 21(12):2745-58. PubMed ID: 22422766 [Abstract] [Full Text] [Related]
33. The spinal muscular atrophy disease protein SMN is linked to the Rho-kinase pathway via profilin. Nölle A, Zeug A, van Bergeijk J, Tönges L, Gerhard R, Brinkmann H, Al Rayes S, Hensel N, Schill Y, Apkhazava D, Jablonka S, O'mer J, Srivastav RK, Baasner A, Lingor P, Wirth B, Ponimaskin E, Niedenthal R, Grothe C, Claus P. Hum Mol Genet; 2011 Dec 15; 20(24):4865-78. PubMed ID: 21920940 [Abstract] [Full Text] [Related]
36. Interaction between alpha-COP and SMN ameliorates disease phenotype in a mouse model of spinal muscular atrophy. Custer SK, Astroski JW, Li HX, Androphy EJ. Biochem Biophys Res Commun; 2019 Jun 25; 514(2):530-537. PubMed ID: 31060774 [Abstract] [Full Text] [Related]
37. Established Stem Cell Model of Spinal Muscular Atrophy Is Applicable in the Evaluation of the Efficacy of Thyrotropin-Releasing Hormone Analog. Ohuchi K, Funato M, Kato Z, Seki J, Kawase C, Tamai Y, Ono Y, Nagahara Y, Noda Y, Kameyama T, Ando S, Tsuruma K, Shimazawa M, Hara H, Kaneko H. Stem Cells Transl Med; 2016 Feb 25; 5(2):152-63. PubMed ID: 26683872 [Abstract] [Full Text] [Related]
38. Motor transmission defects with sex differences in a new mouse model of mild spinal muscular atrophy. Deguise MO, De Repentigny Y, Tierney A, Beauvais A, Michaud J, Chehade L, Thabet M, Paul B, Reilly A, Gagnon S, Renaud JM, Kothary R. EBioMedicine; 2020 May 25; 55():102750. PubMed ID: 32339936 [Abstract] [Full Text] [Related]
39. Survival motor neuron SMN1 and SMN2 gene promoters: identical sequences and differential expression in neurons and non-neuronal cells. Boda B, Mas C, Giudicelli C, Nepote V, Guimiot F, Levacher B, Zvara A, Santha M, LeGall I, Simonneau M. Eur J Hum Genet; 2004 Sep 25; 12(9):729-37. PubMed ID: 15162126 [Abstract] [Full Text] [Related]